Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-08-05 Wang Xiaodong Director Sale −100 $197.65 $20K 100
2022-08-05 Wang Xiaodong Director Sale −100 $198.77 $20K 0
2022-08-05 Wang Xiaodong Director Sale −300 $186.56 $56K 4,700
2022-08-05 Wang Xiaodong Director Sale −200 $188.87 $38K 4,500
2022-08-05 Wang Xiaodong Director Sale −100 $190.19 $19K 4,400
2022-08-05 Wang Xiaodong Director Sale −100 $191.60 $19K 4,300
2022-08-05 Wang Xiaodong Director Sale −888 $193.25 $172K 3,412
2022-08-05 Wang Xiaodong Director Sale −1,644 $194.03 $319K 1,768
2022-08-05 Wang Xiaodong Director Sale −968 $195.45 $189K 800
2022-08-05 Wang Xiaodong Director Sale −600 $196.53 $118K 200
2022-08-05 Wang Xiaodong Director Sale −100 $197.65 $20K 100
2022-08-05 Wang Xiaodong Director Sale −100 $198.76 $20K 0
2022-07-01 Wang Julia Aijun Chief Financial Officer Sale −317 $158.50 $50K 0
2022-07-01 Wang Julia Aijun Chief Financial Officer Sale −295 $158.50 $47K 0
2022-06-27 Wang Lai Global Head of R&D Sale −458 $177.32 $81K 0
2022-06-22 OYLER JOHN Chief Executive Officer Grant or award +334,009 2,070,913
2022-06-22 OYLER JOHN Chief Executive Officer Grant or award · Share Option (Right to Buy) +1,887,678 1,887,678
2022-06-22 Wang Lai Global Head of R&D Grant or award +125,255 1,509,989
2022-06-22 Wang Lai Global Head of R&D Grant or award · Share Option (Right to Buy) +707,876 707,876
2022-06-22 Wang Julia Aijun Chief Financial Officer Grant or award +104,377 245,583

Page 50 of 71 · 1,406 trades